News
StockStory.org on MSN14h
AMRX Q1 Earnings Call: Miss on Revenue, Margin Expansion, and Product Pipeline ProgressPharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) in Q1 CY2025, but sales rose 5.5% year on year to $695.4 million. On the other hand, the company’s full-year revenue guidance of $3.05 ...
StockStory.org on MSN15h
MTD Q1 Earnings Call: Tariffs, Supply Chain Shifts, and Margin Mitigation Take Center StagePrecision measurement company Mettler-Toledo (NYSE:MTD) reported Q1 CY2025 results , but sales fell by 4.6% year on year to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback